24/7 Market News Snapshot 11 April, 2025 – Venus Concept Inc. Common Stock (NASDAQ:VERO)

April 11, 2025

DENVER, Colo., 11 April, 2025 (www.247marketnews.com) – (NASDAQ:VERO) are discussed in this article.
Venus Concept Inc. (VERO) has recently shown a substantial bullish trend in pre-market trading, reaching a price of $4.695, which represents a notable increase of 15.64% from the prior day’s close of $4.060. This significant uptick points to robust investor interest and indicates the potential for continued upward momentum in the company’s stock. With a trading volume of 7.89 million shares, investor enthusiasm is at an elevated level. Analysts will be watching technical indicators, including moving averages, to identify patterns that suggest sustained bullish activity, contingent on the overcoming of key resistance levels.

In addition to the favorable trading performance, Venus Concept has announced a registered direct offering aimed at enhancing its financial standing and facilitating future growth initiatives. The company has entered agreements for the sale of 386,700 shares of its common stock, priced at $4.06 per share. Expected to close on or around April 14, 2025, this offering is contingent upon standard closing conditions. H.C. Wainwright & Co. is acting as the sole placement agent for the transaction, which is expected to generate approximately $1.5 million in gross proceeds, before deducting associated fees and expenses.

The net proceeds from the offering are meant for general corporate purposes, underscoring Venus Concept’s commitment to advancing its innovative medical aesthetic product lineup. With a diverse portfolio that includes leading devices such as Venus Versa, Venus Legacy, and NeoGraft®, the company is dedicated to providing cutting-edge, minimally invasive solutions in the aesthetic sector. This strategic financial move, combined with strong market activity, positions Venus Concept to further its mission of innovation in medical aesthetics while responding to the evolving demands of healthcare providers and patients.

Related news for (VERO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.